Out of the electronic health records (EHRs) of patients seen at Vanderbilt University Medical Center, a team in the Department of Biomedical Informatics is creating a COVID-19 patient registry as a platform for research.

Health care workers at Vanderbilt University Medical Center at high risk of exposure to COVID-19 can participate in a randomized, controlled clinical trial testing the effectiveness of the drug hydroxychloroquine (HCQ) in preventing infection.

When in-person visits to Vanderbilt Eskind Diabetes Clinic needed to be quickly converted to telehealth appointments in response to COVID-19, a novel solution was hatched to bring both clinicians and patients up to speed on videoconferencing.

A team of Vanderbilt researchers constructed polygenic risk scores (PRS) based on genomic variants associated with eight common cancers and concluded they could potentially be used for personalized risk assessments.

Vanderbilt University Medical Center is participating in a multisite clinical trial to test a potential new medication for treating core deficits of autism spectrum disorders in children ages 2-4.

A study by Vanderbilt research-ers supports the clinical development of a new second-line treatment for metastatic melanoma.

Matthew Bacchetta, MD, MBA, MA, associate professor of Thoracic Surgery and adjunct associate professor of Biomedical Engineering, has been inducted to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).